Banner
Structure

1-(2-Tetrahydropyranyl)-1H-pyrazole-4-boronic acid neopentyl glycol ester

CAS
1072944-26-3
Catalog Number
ACM1072944263
Category
Other Products
Molecular Weight
264.1
Molecular Formula
C13H21BN2O3

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources

Specification

Synonyms
1072944-26-3, 1-(2-TETRAHYDROPYRANYL)-1H-PYRAZOLE-4-BORONIC ACID NEOPENTYL GLYCOL ESTER, 4-(5,5-DIMETHYL-1,3,2-DIOXABORINAN-2-YL)-1-(TETRAHYDRO-2H-PYRAN-2-YL)-1H-PYRAZOLE, CTK6B2291, MolPort-002-054-877, ANW-41725, AG-A-67918, 1-(THP)-4-(Neopentylglycolato)-pyrazole, A-4438, 1-(2-Tetrahydropyranyl)-1H-pyrazole-4-boronic acid neopentyl glycol ester,, 1-(2-Tetrahydropyranyl)-1H-pyrazole-4-boronic acid neopentylglycol ester, 1-(Tetrahydro-2H-pyran-2-yl)-4-(5,5-dimethyl-[1,3,2]dioxaborinan-2-yl)-pyrazole
IUPAC Name
4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-1-(oxan-2-yl)pyrazole
Canonical SMILES
B1(OCC(CO1)(C)C)C2=CN(N=C2)C3CCCCO3
InChI Key
YVZAPDBXQZXBDN-UHFFFAOYSA-N
Boiling Point
424.3ºC at 760 mmHg
Flash Point
210.4ºC
Density
1.2g/cm³
Exact Mass
264.16500
H-Bond Acceptor
4
H-Bond Donor
0

Downstream Synthesis Route 1

  • 1072944-26-3
  • 2280839-84-9
  • 2280848-54-4

Reference: [1]Current Patent Assignee: TAISHO PHARMACEUTICAL HOLDINGS CO LTD - EP3666766, 2020, A1
Location in patent: Paragraph 1250

Downstream Synthesis Route 2

  • 1072944-26-3
  • 2415255-70-6
  • 2415255-71-7

Reference: [1]Current Patent Assignee: ONO PHARMACEUTICAL CO LTD - US2021/253615, 2021, A1
Location in patent: Paragraph 0156; 0407-0409

* For details of the synthesis route, please refer to the original source to ensure accuracy.

Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Inquiry Basket
qrcodex
Download
Verification code
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.